chr1-151763412-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031420.4(MRPL9):c.68G>A(p.Arg23Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000495 in 1,412,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.68G>A | p.Arg23Gln | missense_variant | 1/7 | ENST00000368830.8 | NP_113608.1 | |
OAZ3 | NM_001134939.1 | c.32+245C>T | intron_variant | NP_001128411.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL9 | ENST00000368830.8 | c.68G>A | p.Arg23Gln | missense_variant | 1/7 | 1 | NM_031420.4 | ENSP00000357823 | P1 | |
ENST00000512280.1 | n.354G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000294 AC: 5AN: 170084Hom.: 0 AF XY: 0.0000220 AC XY: 2AN XY: 91028
GnomAD4 exome AF: 0.00000495 AC: 7AN: 1412766Hom.: 0 Cov.: 32 AF XY: 0.00000286 AC XY: 2AN XY: 698392
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.68G>A (p.R23Q) alteration is located in exon 1 (coding exon 1) of the MRPL9 gene. This alteration results from a G to A substitution at nucleotide position 68, causing the arginine (R) at amino acid position 23 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at